COX4I1 and neoplasm: Furthermore, NDUFB8, SDHB, UQCRC2, and COX4I1 gene expression showed a statistically significant decrease in non-responder CRC tumor-derived cell lines after oxaliplatin treatment, while no significant effects were observed in ATP5A gene expression (Figure 4H).